Symbol Lookup

Wednesday March 04, 2015 7:12 PM ET. Data delayed 15 minutes.
18.60
0.17 (0.92%)
Bid/Lots
8.24/1
Ask/Lots
26.00/2
Open/Prev Close
18.33/18.43
Day Range
18.26-18.75
52-Week Range
14.00-28.06
Vol/Avg Daily Vol
173.6K/80.7K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Trinity Biotech Announces Results for Q4 and Fiscal Year 2014
8:47AM ET on Tuesday Mar 03, 2015 by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for fiscal year 2014 and the quarter ended December 31, 2014.

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2014 Financial Results
10:44AM ET on Wednesday Feb 25, 2015 by GlobeNewswire

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, March 3,...

Trinity Biotech Says Trial of High Sensitivity Troponin I Product Restarts
10:28AM ET on Monday Feb 23, 2015 by Midnight Trader
10:28 AM EST, 02/23/2015 (MT Newswires) -- Trinity Biotech (TRIB) said the U.S. clinical trial of its Troponin I point-of-care product has restarted and is expected to be completed by end July, with submission to the U.S. Food and Drug Administra...
Trinity Biotech Announces Recommencement of US Clinical Trials on Its Point-of-Care, High Sensitivity Troponin I Product
10:18AM ET on Monday Feb 23, 2015 by GlobeNewswire

Trinity Biotech plc. (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that late last week it shipped Meritas Troponin I product to the USA for the ...

Company Information

Trinity Biotech plc (Trinity Biotech), is an Ireland-based company that develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The Company is a provider of raw materials to the life sciences industry and research institutes globally through the Company subsidiary, Fitzgerald Industries. Trinity Biotech markets its portfolio of over 400 products to customers in 110 countries around the world. Trinity Biotech has manufacturing facilities in Bray, Ireland, in Jamestown, New York, Carlsbad, California and Kansas City, Missouri in the United States. On July 26, 2013, it acquired Immco Diagnostics Inc.

CONTACT INFORMATION

HeadquartersIDA Business Park, Co Wicklow
BRAY, Ireland
Phone--
Fax--

EXECUTIVE OFFICERS

Executive Chairman of the BoardRonan O'Caoimh
Chief Financial Officer, SecretaryKevin Tansley
Chief Operating Officer, Executive DirectorRory Nealon
Chief Scientific Officer, Executive DirectorJames Walsh
Non-Executive DirectorClinton Severson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$425.9MBeta0.59
Revenue (TTM)$103.6MEPS$1.84
Shares Out.23.1MBook Value$8.16
Dividend Yield1.18%P/E10.0x
Annual Dividend Rate$0.22Price/Sales (TTM)4.1
Ex-Div Date6/6/14P/Cash Flow (TTM)--
Pay Date7/1/14Operating Margin18.11%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample